The partnership will further the system’s research and development of cell-targeted nucleic acid and gene editing therapies which Pfizer may apply to its investigational programs, according to a Feb. 12 system news release. It will also bring together UT Southwestern’s advances in RNA-based biology and therapies with Pfizer’s rapid manufacturing capabilities.
UT Southwestern’s lab has been working on RNA-based delivery systems for more than a decade.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
